Posts by: Margarida Azevedo

Margarida Azevedo

Margarida graduated with a BS in Health Sciences from the University of Lisbon and a MSc in Biotechnology from Instituto Superior Técnico (IST-UL). She worked as a molecular biologist research associate at a Cambridge UK-based biotech company that discovers and develops therapeutic, fully human monoclonal antibodies.

April 19, 2016April 19, 2016

Gene Variant May Contribute to Increased Colorectal Cancer Risk in African-Americans

Wistar Institute researchers have identified a single variant in an important tumor suppressor gene only found in Africans and African-Americans that might explain disparities in the incidence of certain cancers ... Read more

January 25, 2016January 25, 2016

Molecular Link Between Obesity and Increased Risk of Colon Cancer Uncovered

Thomas Jefferson University researchers have found the molecular connection between obesity and an increased risk of colorectal cancer, while also identifying an FDA-approved drug that could prevent the cancer from developing. ... Read more

January 3, 2016January 4, 2016

Colorectal Cancer Resistance to Treatment May Have Molecular Cause

University of Texas MD Anderson Cancer Center researchers have linked epidermal growth factor receptor regulation to colorectal cancer tumorigenesis, poor patient outcomes, and resistance to treatment with cetuximab (Erbitux). The ... Read more